These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37905677)

  • 21. The nature of postural tremor in Parkinson disease.
    Dirkx MF; Zach H; Bloem BR; Hallett M; Helmich RC
    Neurology; 2018 Mar; 90(13):e1095-e1103. PubMed ID: 29476038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tremor and dopamine agonists.
    Elble RJ
    Neurology; 2002 Feb; 58(4 Suppl 1):S57-62. PubMed ID: 11909986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive Stress Reduces the Effect of Levodopa on Parkinson's Resting Tremor.
    Zach H; Dirkx MF; Pasman JW; Bloem BR; Helmich RC
    CNS Neurosci Ther; 2017 Mar; 23(3):209-215. PubMed ID: 28071873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson's disease.
    Blahak C; Wöhrle JC; Capelle HH; Bäzner H; Grips E; Weigel R; Hennerici MG; Krauss JK
    J Neurol; 2007 Feb; 254(2):169-78. PubMed ID: 17334951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.
    Foster NL; Newman RP; LeWitt PA; Gillespie MM; Larsen TA; Chase TN
    Ann Neurol; 1984 Oct; 16(4):505-8. PubMed ID: 6149724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor.
    Dirkx MF; Zach H; van Nuland A; Bloem BR; Toni I; Helmich RC
    Brain; 2019 Oct; 142(10):3144-3157. PubMed ID: 31509182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latency of re-emergent tremor in Parkinson's disease is influenced by levodopa.
    Wilken M; Rossi MD; Rivero AD; Hallett M; Merello M
    Parkinsonism Relat Disord; 2019 Apr; 61():166-169. PubMed ID: 30348494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD; Baxter RC; Marsden CD; Rees JE
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ropinirole for the treatment of tremor in early Parkinson's disease.
    Schrag A; Keens J; Warner J;
    Eur J Neurol; 2002 May; 9(3):253-7. PubMed ID: 11985633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levodopa does not aggravate postural tremor in Parkinson's disease.
    Kulisevsky J; Avila A; Barbanoj M; Antonijoan R; Torres J; Arcelus R
    Clin Neuropharmacol; 1995 Oct; 18(5):435-42. PubMed ID: 8665557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tremor in Parkinson disease: acute response to oral levodopa.
    Tedeschi G; Sasso E; Marshall RW; Bonavita V
    Ital J Neurol Sci; 1990 Jun; 11(3):259-63. PubMed ID: 2201664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinsonian action tremor: interference with object manipulation and lacking levodopa response.
    Raethjen J; Pohle S; Govindan RB; Morsnowski A; Wenzelburger R; Deuschl G
    Exp Neurol; 2005 Jul; 194(1):151-60. PubMed ID: 15899252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's disease improvement after the addition of levodopa-carbidopa to anticholinergic treatment. An open controlled study.
    Agnoli A; Ruggieri S; Denaro A; Lelli A
    Acta Neurol (Napoli); 1978 Oct; 33(5):436-42. PubMed ID: 756675
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in prefrontal cortical activity and turning in response to dopaminergic and cholinergic therapy in Parkinson's disease: A randomized cross-over trial.
    Vitorio R; Stuart S; Giritharan A; Quinn J; Nutt JG; Mancini M
    Parkinsonism Relat Disord; 2021 May; 86():10-14. PubMed ID: 33813359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tremor in Parkinson's Disease: From Pathophysiology to Advanced Therapies.
    Abusrair AH; Elsekaily W; Bohlega S
    Tremor Other Hyperkinet Mov (N Y); 2022; 12():29. PubMed ID: 36211804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
    van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
    Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Nutt JG; Carter JH; Carlson NE
    Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Initial treatment of Parkinson's disease].
    Kulisevsky J; López-Villegas D
    Rev Neurol; 1997 Aug; 25 Suppl 2():S163-9. PubMed ID: 9280684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prefrontal Cortex Activity and Gait in Parkinson's Disease With Cholinergic and Dopaminergic Therapy.
    Stuart S; Morris R; Giritharan A; Quinn J; Nutt JG; Mancini M
    Mov Disord; 2020 Nov; 35(11):2019-2027. PubMed ID: 32830901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.